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ABSTRACT 
CONTEXT AND OBJECTIVE: Healthcare professionals need to instill the process of prevention, control 
and treatment of people infected with HIV into care practice. Through maintaining preventive treatment 
among HIV-infected pregnant women, it has been demonstrated that prophylactic antiretroviral therapy, 
scheduled cesarean section and the prohibition of breastfeeding significantly reduce vertical HIV transmis-
sion. This study aimed to assess the rates of vertical HIV transmission in a specialized service and identify 
the factors associated with it. 
DESIGN AND SETTING: Cross-sectional study developed at the University Hospital of Santa Maria (RS), Brazil. 
METHODS: A cross-sectional study was conducted on a sample of 198 notification forms and medical 
records of HIV-positive pregnant women and exposed children. 
RESULTS: The vertical transmission rate was 2.4%, and three children had been infected by vertical HIV 
transmission. The statistically significant risk factor was the use of injectable drugs. Delayed reporting of 
pregnancy, absence of antiretroviral therapy during pregnancy, lack of proper prenatal care, incapacity to 
perform viral load detection tests and CD4+ T cell counts and obstetric and maternal clinical complica-
tions were reported. 
CONCLUSIONS: The vertical transmission rate was high and the recommended intervention measures 
were not adopted in full. Adequate prophylactic measures need to be implemented in HIV-positive preg-
nant women prenatally and during the antenatal, delivery and postpartum periods. 
RESUMO
CONTEXTO E OBJETIVO: Os profissionais de saúde precisam introduzir o processo de prevenção, controle 
e tratamento das pessoas infectadas com HIV na prática assistencial. Manter o tratamento preventivo em 
gestantes infectadas pelo HIV demonstra que a terapia antirretroviral profilática, a cesariana programada 
e a proibição da amamentação reduzem significativamente a transmissão vertical do HIV. Este estudo tem 
como objetivo avaliar as taxas de transmissão vertical do HIV em um serviço especializado e identificar os 
fatores associados. 
TIPO DE ESTUDO E LOCAL: Estudo transversal desenvolvido no Hospital Universitário de Santa Maria 
(RS), Brasil. 
MÉTODOS: Estudo transversal foi conduzido utilizando amostra de 198 fichas de notificação e prontuários 
de mulheres grávidas HIV-positivas e crianças expostas.
RESULTADOS: A taxa de transmissão vertical foi de 2,4%, e três crianças foram infectadas por transmissão 
vertical do HIV. O fator de risco estatisticamente significativo foi o uso de drogas injetáveis. Comunica-
ção tardia da gravidez, ausência de terapia antirretroviral durante a gravidez, falta de cuidados pré-natais 
adequados, incapacidade de realizar testes virais de detecção de carga e contagem de células T CD4+ e 
complicações clínicas obstétricas e maternas foram relatadas.
CONCLUSÕES: A taxa de transmissão vertical foi elevada e medidas de intervenção recomendadas não 
foram adotadas na íntegra. Medidas profiláticas adequadas precisam ser implementadas em mulheres 
grávidas HIV-positivas no pré-natal e durante os períodos pré-natal, intraparto e pós-parto.
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INTRODUCTION
Vertical transmission of human immunodeficiency virus (HIV) is 
characterized by passage of the virus from the mother to the child 
through the placenta during pregnancy, at the time of childbirth 
or through breastfeeding.1-4 Children with HIV infection who 
develop acquired immunodeficiency syndrome (AIDS) stand out 
within the context of the epidemic. Its epidemiological growth is 
due to the feminization process and the increased survival rate 
among individuals infected through vertical transmission.5,6
In Brazil, the first cases of vertical transmission were reported 
in 1985.7 The Brazilian Ministry of Health uses the incidence rates 
among children under five years of age as an indicator for moni-
toring vertical transmission. Between 1980 and 2013, 12,551 cases 
of AIDS in children under 13 years of age who had been exposed 
to vertical transmission were reported in the notification infor-
mation system.1
Screening of pregnant women and early implementation of 
antiretroviral prophylaxis are issues that require more attention.8 
Healthcare professionals need to instill the process of prevention, 
control and care of people infected with HIV into general practice. 
Through administering preventive treatment among HIV-infected 
pregnant women, it has been demonstrated that prophylactic 
antiretroviral therapy, scheduled cesarean section and prohibi-
tion of breastfeeding significantly reduces HIV transmission from 
mother to child.9,10 
OBJECTIVE
This study aimed to assess the rate of vertical HIV transmission 
in a specialized service and identify the factors associated with it.
METHODS
A cross-sectional study was conducted between 2008 and 2012 at 
the University Hospital of Santa Maria, Rio Grande do Sul, Brazil, 
where HIV-infected pregnant women gave birth. The study was 
approved by the Research Ethics Committee of the Paulista 
School of Nursing (CAEE No: 16395413.4.0000.5505), in accor-
dance with Resolution 466/2012 of the National Health Council 
and also with international rules.
The study participants were identified through records kept 
in the information system for notifiable diseases and through the 
medical records of HIV-positive women. The sample comprised the 
entire population of children at this hospital who were exposed to 
HIV between 2008 and 2012. Miscarriages and cases of stillbirths 
among pregnant women infected with HIV were excluded.
The primary variable was the prevalence of vertical HIV trans-
mission. Secondary variables included sociodemographic vari-
ables (maternal age, maternal education, city of residence, area of 
residence and occupation of the mother); maternal exposure to 
HIV (sexual partners, partner’s HIV status and use of injectable 
drugs); pregnancy, prenatal care, early prenatal care, antiretrovi-
ral therapy during pregnancy, treatment regimen, reasons for not 
performing antiretroviral prophylaxis during pregnancy, maternal 
HIV viral load (PCR-RNA) and CD4+ T cell counts during preg-
nancy; complications during pregnancy (clinical, obstetric and 
coinfections); management during delivery (delivery type, deliv-
ery performance of municipality, use of injectable antiretrovirals, 
rupture of membranes, episiotomy, lactation inhibitors, quick tests 
before delivery and pregnancy outcome); and finally, care of the 
newborn (early administration of oral zidovudine, full-time use 
of oral zidovudine, breastfeeding, cross lactation, viral load, HIV 
screening test and confirmatory rapid anti-HIV serological test).
Descriptive statistics (absolute frequency, mean, median, stan-
dard deviation, minimum and maximum) of the independent vari-
ables were performed to characterize the HIV-infected pregnant 
women and exposed children. The dependent variable was used to 
calculate the rate of vertical HIV transmission. Fisher’s exact test 
and nonparametric Mann-Whitney tests were used to assess the 
associations between the dependent and independent variables.
We used the chi-square test to compare quantitative variables 
between HIV-positive and HIV-negative children and binary logis-
tic regression to verify the risk factors for vertical HIV transmis-
sion. The data were analyzed using the Statistical Package for the 
Social Sciences (SPSS) 21.0. For each point estimate, 95% confi-
dence intervals were derived, and a statistical significance level 
of 5% was used.
RESULTS
Over the study period, there were 198 eligible cases of HIV-
infected women who gave birth in the institution. Therefore, 198 
children were exposed to HIV during pregnancy. The baseline 
characteristics of the pregnant women and exposed children are 
shown in Table 1.
The prevalence of vertical transmission in this population was 
2%, and 98% of the exposed children underwent chemoprophy-
laxis; 99% were not breastfed.
Among the possible risk factors for HIV transmission, there 
were significant associations with use of injectable drugs by the 
pregnant woman, confirmation of HIV infection during prenatal 
exams, antiretroviral drug use during pregnancy, viral load result, 
CD4+ T cell counts or presence of associated infections (Table 2). 
Through assessing the clinical characteristics of the pregnant 
women infected with HIV, it was found that 39.4% had obstetric 
complications, 36.4% suffered from coinfections and 30.8% dem-
onstrated presence of maternal clinical complications.
Regarding the number of hours after birth at which antiret-
roviral therapy was started for the child, a statistically significant 
difference (P = 0.03) was found between those infected with HIV 
and those that were not infected.
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DISCUSSION
In Brazil, the prevalence of vertical HIV transmission is 1%. 
However, the rate seen in the hospital service examined here 
was 2%, which is more than double the national average. It was 
observed that this rate was 3.4 times higher than the prevalence 
in this service, over the period between 2002 and 2006, when 
it was 0.7%. Some of the factors that may have influenced the 
increase in vertical transmission are late notification of preg-
nancies of infected women for the health service, absence of the 
use of antiretroviral therapy during pregnancy, lack of perception 
of prenatal complications, obstetric complications and quality of 
maternal clinics. In 2012, the detection rate for AIDS in children 
under 5 years of age was 3.4/100,000. This rate has been used as 
an indicator to monitor vertical HIV transmission.11-13
The present study did not allow identification of risk factors 
for vertical transmission, mainly because of absence of data in the 
files. However, there is evidence that clinical and immunological 
factors (recent infection, vaginal infections, viral load of pregnant 
women and low CD4+ count), obstetric issues (vaginal delivery 
and premature birth), factors relating to the newborn (breast-
feeding and antiretroviral prophylaxis for newborns), absence of 
antiretroviral therapy during pregnancy and behavioral factors 
(young maternal age and use of drugs by pregnant women) influ-
ence vertical transmission.14
With regard to clinical and immunological factors, it was 
found in this study that 36.4% of the pregnant women had recent 
infections and 11.1% had vaginal infections. Both types of infec-
tion boost vertical transmission because they weaken immunity 
in the pregnant woman and fetus and therefore result in greater 
amounts of secretions with high viral load at the time of deliv-
ery.14-17 This demonstrates the importance of early diagnosis and 
subsequent treatment in order to reduce the risk factors for ver-
tical transmission.
Since the hospital service examined here provides care for 
cases of high complexity and mainly caters to pregnant women 
at high risk prenatally, only 22% of the women underwent vagi-
nal delivery and 28.3% gave birth prematurely. The high rate of 
Table 1. Baseline characteristics of HIV-infected pregnant 
women and exposed children (n = 198) at the University 
Hospital of Santa Maria (RS), Brazil, between 2008 and 2012
Characteristics
Median 
(minimum-
maximum)
Pregnant women n (%)
Age in years 27 (14-45)
Schooling in years 7 (0-18)
Fixed sexual partner 75 (37.9)
Sexual partner infected with HIV 33 (16.7)
Injectable drug abuse 19 (9.6)
Use of lactation inhibitor 195 (97.0)
First prenatal consultation held in the first 
trimester
27 (13.6)
Vaginal birth 41 (20.7)
Threat of abortion 7 (3.5)
Anemia 6 (3.0)
Intrauterine growth restricted 2 (1.0)
Maternal hypertension 10 (5,1)
Disruption of membranes before delivery 24 (12.1)
Maternal infection with syphilis 10 (5.1)
Maternal infection with toxoplasmosis 25 (12.6)
Maternal infection with hepatitis C virus 14 (7.1)
Maternal urinary infection 19 (9.6)
Preterm labor 36 (18.2)
Presence of vaginal infections 22 (11.1)
Time (in hours) of membrane rupture, median 
(minimum-maximum)
5 (1-648)
Viral load detectable 81 (40.9)
CD4+ T lymphocyte count, mean (standard 
deviation)
465.9 (249.5)
Children exposed
Infected with HIV 4 (2.0) 
Did not breastfeed 196 (99.0)
No cross-lactation 198 (100.0)
Underwent chemoprophylaxis 194 (98.0)
Variables OR
CI
P†
Lower Upper
Injectable drug use by pregnant women: no*; yes 1.11 0.90 0.96 0.03
Confirmation of HIV infection: before prenatal period*; prenatal/pregnancy 0.59 1.05 5.31 0.04
Antiretroviral drug use during pregnancy: yes*; no 1.92 1.16 22.30 0.02
Viral load result: detectable; undetectable* 0.71 1.04 11.76 0.04
CD4+ T cell count: up to 350*; 351 or more 1.32 -0.02 0.10 0.05
Presence of associated infections: no*; yes 1.25 1.06 22.87 0.02
Viral load result: detectable; undetectable* 1.15 0.00 0.01 0.02
Table 2. Clinical characteristics of pregnant women infected with HIV at the University Hospital of Santa Maria (RS), Brazil, between 2008 and 2012
*Reference; †Binary logistic regression; OR = odds ratio; CI = confidence interval. 
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premature births shown in this study may be associated with the 
antiretroviral therapy, which has been shown to increase the risk 
of premature delivery.9,10,12,14,16
With regard to risk factors relating to the newborn, 1.5% of 
the newborns in this study were breastfed and 97.1% underwent 
chemoprophylaxis. There is evidence that breastfeeding without 
antiretroviral treatment for the mother or the child increases the 
risk of vertical transmission by 91%. One factor that helps reduce 
the possibility of vertical transmission is the use of medication to 
inhibit lactation, and 95.9% of the pregnant women in this study 
were found to be using this medication.4,8,12,14-18
Use of antiretroviral drugs during pregnancy increases the 
CD4+ T lymphocyte cell counts and consequently reduces the viral 
load, thereby decreasing the risk of intrauterine vertical transmis-
sion. This should be combined with early detection of HIV infec-
tion in pregnant women. However, 38.3% of the women in this 
study were diagnosed with infection prenatally or later. Only 33.3% 
of the pregnant women received adequate prenatal care starting 
from the first trimester of pregnancy, and this lack of care can 
contribute towards the risk of vertical transmission, abortion and 
perinatal mortality.9,10,15-17
Injectable drug abuse, which doubles the risk of vertical trans-
mission and increases the risk of abortion sixfold,10 was seen in the 
cases of 9.6% of the pregnant women in this study. For pregnant 
women who use other drugs, harm reduction strategies should be 
discussed. It needs to be emphasized that they should use condoms 
and not share syringes and needles, if they are using injectable 
drugs. In this manner, users can reduce their own risk of reinfec-
tion and transmission to their sexual partners.19
The diagnosis of vertical transmission needs to be confirmed 
by performing a screening test for HIV-1 and HIV-2 and at least 
one confirmatory test. In the event of positive results, a new sam-
ple should be collected to confirm the positive results from the 
first sample.3,4,13 
The cases of 81.1% of the HIV-positive pregnant women were 
only notified in the third trimester, thus indicating that there were 
delays in notification. In Brazil, notification is supposed to occur 
at the time of detection of HIV infection in pregnant women and/
or children infected by vertical transmission.4
Healthcare professionals need to work towards reducing ver-
tical HIV transmission through providing recommendations for 
interventions, early identification of women exposed to HIV, imple-
mentation of preventive measures and appropriate use of antiret-
roviral therapy in prenatal care. Controlling AIDS can prove to 
be a challenge.8
The limitations of this study included its cross-sectional design, 
which did not allow causality to be established. Moreover, the pri-
mary source of data was the notification forms and medical records 
of the pregnant women and children exposed to HIV. 
CONCLUSION
This study showed that the rate of vertical transmission in a spe-
cialized service is 2%, twice the national average. Risk factors 
for increased vertical transmission of HIV were: injected drug 
use, confirmation of HIV infection in prenatal period or child-
birth, non-use of antiretroviral drugs during pregnancy, high 
viral load, reduced CD4 T lymphocytes and presence of associ-
ated infections.
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